Expertise in
11
conditions

Dr. Jinesh P. Mehta

Cleveland Clinic Florida (A Nonprofit Corporation)
Weston, FL
Expertise in
11
conditions
Specialties:Pulmonary Medicine | Intensive Care Medicine
Accepting New Patients
Offers Telehealth
Expertise in
11
conditions
OverviewInsuranceLocationsClinical Research

Overview

Jinesh Mehta is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Weston, Florida. MD. Mehta is highly rated in 11 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Interstitial Lung Disease, Acute Interstitial Pneumonia, Emphysema, and Advanced Bronchoscopy. MD. Mehta is currently accepting new patients.

His clinical research consists of co-authoring 17 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Intensive Care Medicine
Licenses
Internal Medicine in FL
Hospital Affiliations
Cleveland Clinic Hospital
Languages Spoken
English
Hindi
Marathi
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Health Options
  •  CareSource
  •  Humana
  •  Florida Blue

Locations

CLEVELAND CLINIC FLORIDA (A NONPROFIT CORPORATION)
2950 Cleveland Clinic Blvd, Weston, FL 33331
954-659-5000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
Enrollment Status: Completed
Publish Date: November 01, 2024
Intervention Type: Drug
Study Drug: Treprostinil Inhalation Powder
Study Phase: Phase 1
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Unknown
Publish Date: August 04, 2023
Intervention Type: Drug
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

17 Total Publications

Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial.
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial.
Journal: American journal of respiratory and critical care medicine
Published: November 12, 2021
Similar Doctors
Expertise in
16
conditions
Dr. Franck F. Rahaghi
Pulmonary Medicine | Intensive Care Medicine
Expertise in
16
conditions
Dr. Franck F. Rahaghi
Pulmonary Medicine | Intensive Care Medicine

Cleveland Clinic Florida (A Nonprofit Corporation)

2950 Cleveland Clinic Blvd, 
Weston, FL 
954-659-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Franck Rahaghi is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Weston, Florida. Dr. Rahaghi is highly rated in 16 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Alpha-1 Antitrypsin Deficiency (AATD), Interstitial Lung Disease, Lung Transplant, and Vertebroplasty. Dr. Rahaghi is currently accepting new patients.

Expertise in
35
conditions
Dr. Elio E. Donna
Pulmonary Medicine | Intensive Care Medicine
Expertise in
35
conditions
Dr. Elio E. Donna
Pulmonary Medicine | Intensive Care Medicine

University Of Miami

1611 Nw 12 Th Ave, Jackson Memorial Hospital, 
Miami, FL 
 (22.1 mi)
305-355-5000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Elio Donna is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Miami, Florida. Dr. Donna is highly rated in 35 conditions, according to our data. His top areas of expertise are Lymphofollicular Hyperplasia, Lung Metastases, Lung Cancer, Pneumonia, and Advanced Bronchoscopy. Dr. Donna is currently accepting new patients.

Expertise in
53
conditions
Dr. Bin Q. Wang
Intensive Care Medicine | Hospital Medicine | Pediatrics
Expertise in
53
conditions
Dr. Bin Q. Wang
Intensive Care Medicine | Hospital Medicine | Pediatrics

Pediatric Critical Care Of S Fl PA

3501 Johnson St, 
Hollywood, FL 
 (12.3 mi)
954-265-6301
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bin Wang is an Intensive Care Medicine specialist and a Hospital Medicine provider in Hollywood, Florida. Dr. Wang is highly rated in 53 conditions, according to our data. Her top areas of expertise are Cerebral Hypoxia, Biliary Atresia, Gliomatosis Cerebri, Osteotomy, and Endoscopy. Dr. Wang is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile